Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Fassan

Showing results (501-510 of 596) with videos related to

Pageof 60
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 20, 2025
HER2, HER3, and Mismatch Repair Protein Expression in Stage IV Small Bowel Adenocarcinoma: Results From a Multicenter SeriesAlessandro Vanoli, Tommaso Colella, Paola Parente, et al.
Histopathology|November 21, 2023
IDH1-mutated Crohn's disease-associated small bowel adenocarcinomas: Distinctive pathological features and association with MGMT methylation and serrated-type dysplasiaCamilla Guerini, Daniela Furlan, Giuseppina Ferrario, et al.
Human Pathology|July 19, 2022
Genomic characterization of undifferentiated sarcomatoid carcinoma of the pancreasAnastasios Gkountakos, Andrea Mafficini, Emil Lou, et al.
Oncotarget|May 29, 2014
Multigene mutational profiling of cholangiocarcinomas identifies actionable molecular subgroupsMichele Simbolo, Matteo Fassan, Andrea Ruzzenente, et al.
World Journal of Gastrointestinal Oncology|July 12, 2024
Association between <i>Helicobacter pylori</i> infection, mismatch repair, HER2 and tumor-infiltrating lymphocytes in gastric cancerCarlos A Castaneda, Miluska Castillo, Luis A Bernabe, et al.
Translational Oncology|November 19, 2018
miR-224 Is Significantly Upregulated and Targets Caspase-3 and Caspase-7 During Colorectal CarcinogenesisMatteo Fassan, Ri Cui, Pierluigi Gasparini, et al.
Pathologica|July 8, 2025
The routine use of a digital tool for the tumor cell fraction quantification in molecular pathology: an international validation of QuANTUMVincenzo L'Imperio, Giulia Capitoli, Giorgio Cazzaniga, et al.
Translational Lung Cancer Research|November 19, 2020
SRC and PIM1 as potential co-targets to overcome resistance in MET deregulated non-small cell lung cancerIlaria Attili, Laura Bonanno, Niki Karachaliou, et al.
European Journal of Haematology|November 15, 2020
Histology of the spleen in immune thrombocytopenia: clinical-pathological characterization and prognostic implicationsMarco Pizzi, Alberto Friziero, Fabrizio Vianello, et al.
Journal of the National Cancer Institute|July 31, 2024
Immune and gene-expression profiling in estrogen receptor low and negative early breast cancerDavide Massa, Claudio Vernieri, Lorenzo Nicolè, et al.
Pageof 60

Showing results (501-510 of 596) with videos related to

Sort By:
Pageof 60
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 20, 2025
HER2, HER3, and Mismatch Repair Protein Expression in Stage IV Small Bowel Adenocarcinoma: Results From a Multicenter SeriesAlessandro Vanoli, Tommaso Colella, Paola Parente, et al.
Histopathology|November 21, 2023
IDH1-mutated Crohn's disease-associated small bowel adenocarcinomas: Distinctive pathological features and association with MGMT methylation and serrated-type dysplasiaCamilla Guerini, Daniela Furlan, Giuseppina Ferrario, et al.
Human Pathology|July 19, 2022
Genomic characterization of undifferentiated sarcomatoid carcinoma of the pancreasAnastasios Gkountakos, Andrea Mafficini, Emil Lou, et al.
Oncotarget|May 29, 2014
Multigene mutational profiling of cholangiocarcinomas identifies actionable molecular subgroupsMichele Simbolo, Matteo Fassan, Andrea Ruzzenente, et al.
World Journal of Gastrointestinal Oncology|July 12, 2024
Association between <i>Helicobacter pylori</i> infection, mismatch repair, HER2 and tumor-infiltrating lymphocytes in gastric cancerCarlos A Castaneda, Miluska Castillo, Luis A Bernabe, et al.
Translational Oncology|November 19, 2018
miR-224 Is Significantly Upregulated and Targets Caspase-3 and Caspase-7 During Colorectal CarcinogenesisMatteo Fassan, Ri Cui, Pierluigi Gasparini, et al.
Pathologica|July 8, 2025
The routine use of a digital tool for the tumor cell fraction quantification in molecular pathology: an international validation of QuANTUMVincenzo L'Imperio, Giulia Capitoli, Giorgio Cazzaniga, et al.
Translational Lung Cancer Research|November 19, 2020
SRC and PIM1 as potential co-targets to overcome resistance in MET deregulated non-small cell lung cancerIlaria Attili, Laura Bonanno, Niki Karachaliou, et al.
European Journal of Haematology|November 15, 2020
Histology of the spleen in immune thrombocytopenia: clinical-pathological characterization and prognostic implicationsMarco Pizzi, Alberto Friziero, Fabrizio Vianello, et al.
Journal of the National Cancer Institute|July 31, 2024
Immune and gene-expression profiling in estrogen receptor low and negative early breast cancerDavide Massa, Claudio Vernieri, Lorenzo Nicolè, et al.
Pageof 60